A new analysis challenges the clinical trial endpoint Grail is using to evaluate its blood test aimed at simultaneously detecting multiple types of tumors early.
Comments
\(°ロ\)
There's nothing here…
A new analysis challenges the clinical trial endpoint Grail is using to evaluate its blood test aimed at simultaneously detecting multiple types of tumors early.